Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
The top July 4 fireworks, festivals, and food trucks in the Triangle + Maps
Recommended
Do these things indoors and out to keep your home cool in summer heat
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gain Therapeutics Inc
(NQ:
GANX
)
1.290
-0.010 (-0.77%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
380,744
Open
1.310
Bid (Size)
1.250 (1)
Ask (Size)
1.300 (25)
Prev. Close
1.300
Today's Range
1.230 - 1.319
52wk Range
1.200 - 5.330
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
InvestorNewsBreaks – Gain Therapeutics Inc. (NASDAQ: GANX) Releases Pricing of Underwritten Public Offering, Projected to Reach $11M
June 18, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
June 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
-64.41%
-64.41%
1 Month
-46.91%
-46.91%
3 Month
-68.23%
-68.23%
6 Month
-47.77%
-47.77%
1 Year
-72.26%
-72.26%
More News
Read More
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
Via
Benzinga
Gain Therapeutics: Q4 Earnings Insights
March 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 14, 2024
Via
Benzinga
Gold Gains 1%; US Consumer Sentiment Falls In June
June 14, 2024
Via
Benzinga
Dear ARM Stock Fans, Mark Your Calendars for June 24
June 14, 2024
Via
InvestorPlace
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
June 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Gain Therapeutics (GANX) Stock Down 25% Today?
June 14, 2024
Via
InvestorPlace
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 14, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 14, 2024
Via
InvestorPlace
Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
June 13, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics Announces Proposed Public Offering
June 13, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 30, 2024
Via
Benzinga
Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024
May 30, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
GANX Stock Earnings: Gain Therapeutics Beats EPS for Q1 2024
May 14, 2024
Via
InvestorPlace
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
May 14, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
April 24, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
April 08, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
April 02, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer
April 01, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
GANX Stock Earnings: Gain Therapeutics Beats EPS for Q4 2023
March 26, 2024
Via
InvestorPlace
Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
March 26, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics to Present at Public Ventures Discovery Day
March 15, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.